News FAMHP

There are 21 result(s) found based on your search criteria

21-21 from 21 result(s)

Tetrazepam-containing medicines: reassessment of the risk-benefit balance. The famhp position following the recommendation of PRAC

The Pharmacovigilance Risk Assessment Committee (PRAC), which is the Committee for Risk Assessment for pharmacovigilance in the European Medicines Agency (EMA) has reviewed the data available on tetrazepam due to reports of rare but serious skin reactions.

21-21 from 21 result(s)